Molecular Mapping of Sinoatrial Node HCN Channel Expression in the Human Heart

Circulation: Arrhythmia and Electrophysiology

Volumn 8, Issue 5, 2015, Pages 1219-1227

  Li, Ning ^a   Csepe, Thomas A ^a   Hansen, Brian J ^a   Dobrzynski, Halina ^b,c   Higgins, Robert S D ^a   Kilic, Ahmet ^a   Mohler, Peter J ^a   Janssen, Paul M L ^a   Rosen, Michael R ^d   Biesiadecki, Brandon J ^a   Fedorov, Vadim V ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d University of Manchester ^*  (United States)

Author keywords

HCN pacemaker channels; heart failure; human heart; sinoatrial node; sinus node dysfunction

Indexed keywords

CARDIOPLEGIC AGENT; CONNEXIN 43; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL 1; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL 2; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL 4; UNCLASSIFIED DRUG; VIMENTIN; HCN1 PROTEIN, HUMAN; HCN2 PROTEIN, HUMAN; HCN4 PROTEIN, HUMAN; ISOPROTEIN; MUSCLE PROTEIN; POTASSIUM CHANNEL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM PACING; HEART FAILURE; HEART MUSCLE CELL; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESUSCITATION; SINUS NODE; YOUNG ADULT; CARDIAC MUSCLE CELL; METABOLISM;

ADULT; AGED; FEMALE; HEART FAILURE; HUMANS; HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS; IMMUNOBLOTTING; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYOCYTES, CARDIAC; POTASSIUM CHANNELS; PROTEIN ISOFORMS; SINOATRIAL NODE;

EID: 84944680364     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.115.003070     Document Type: Article

References (43)

1. Boyett MR, Honjo H, Kodama I. The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res. 2000;47:658-687.
2. Dobrzynski H, Anderson RH, Atkinson A, Borbas Z, D'Souza A, Fraser JF, Inada S, Logantha SJ, Monfredi O, Morris GM, Moorman AF, Nikolaidou T, Schneider H, Szuts V, Temple IP, Yanni J, Boyett MR. Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues. Pharmacol Ther. 2013;139:260-288. doi: 10.1016/j.pharmthera.2013.04.010.
3. DiFrancesco D. Funny channels in the control of cardiac rhythm and mode of action of selective blockers. Pharmacol Res. 2006;53:399-406. doi: 10.1016/j.phrs.2006.03.006.
4. Fedorov VV, Glukhov AV, Chang R, Kostecki G, Aferol H, Hucker WJ, Wuskell JP, Loew LM, Schuessler RB, Moazami N, Efimov IR. Optical mapping of the isolated coronary-perfused human sinus node. J Am Coll Cardiol. 2010;56:1386-1394. doi: 10.1016/j.jacc.2010.03.098.
5. Zhao J, Csepe TA, Lim P, Hansen BJ, Li N, Kalyanasundaram A, Mohler PJ, Janssen PML, Davies EA, Weiss R, Fedorov VV. Detailed 3D reconstruction of the optically mapped sino-atrial node unravels direct evidence of specialized conduction pathways in the human heart. Heart Rhythm. 2014;11:s102.
6. Shi W, Wymore R, Yu H, Wu J, Wymore RT, Pan Z, Robinson RB, Dixon JE, McKinnon D, Cohen IS. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res. 1999;85:e1-e6.
7. Zicha S, Fernández-Velasco M, Lonardo G, L'Heureux N, Nattel S. Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model. Cardiovasc Res. 2005;66:472-481. doi: 10.1016/j.cardiores.2005.02.011.
8. Chandler NJ, Greener ID, Tellez JO, Inada S, Musa H, Molenaar P, Difrancesco D, Baruscotti M, Longhi R, Anderson RH, Billeter R, Sharma V, Sigg DC, Boyett MR, Dobrzynski H. Molecular architecture of the human sinus node: insights into the function of the cardiac pacemaker. Circulation. 2009;119:1562-1575. doi: 10.1161/CIRCULATIONAHA.108.804369.
9. Wahl-Schott C, Biel M. HCN channels: structure, cellular regulation and physiological function. Cell Mol Life Sci. 2009;66:470-494. doi: 10.1007/s00018-008-8525-0.
10. Fenske S, Krause SC, Hassan SI, Becirovic E, Auer F, Bernard R, Kupatt C, Lange P, Ziegler T, Wotjak CT, Zhang H, Hammelmann V, Paparizos C, Biel M, Wahl-Schott CA. Sick sinus syndrome in HCN1-deficient mice. Circulation. 2013;128:2585-2594. doi: 10.1161/CIRCULATIONAHA.113.003712.
11. Lou Q, Hansen BJ, Fedorenko O, Csepe TA, Kalyanasundaram A, Li N, Hage LT, Glukhov AV, Billman GE, Weiss R, Mohler PJ, Györke S, Biesiadecki BJ, Carnes CA, Fedorov VV. Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping. Circulation. 2014;130:315-324. doi: 10.1161/CIRCULATIONAHA.113.007086.
12. Verkerk AO, Wilders R, Coronel R, Ravesloot JH, Verheijck EE. Ionic remodeling of sinoatrial node cells by heart failure. Circulation. 2003;108:760-766. doi: 10.1161/01.CIR.0000083719.51661.B9.
13. Verkerk AO, Wilders R, van Borren MM, Peters RJ, Broekhuis E, Lam K, Coronel R, de Bakker JM, Tan HL. Pacemaker current (I(f)) in the human sinoatrial node. Eur Heart J. 2007;28:2472-2478. doi: 10.1093/eurheartj/ehm339.
14. Verkerk AO, Wilders R. Pacemaker activity of the human sinoatrial node: an update on the effects of mutations in HCN4 on the hyperpolarization-activated current. Int J Mol Sci. 2015;16:3071-3094. doi: 10.3390/ijms16023071.
15. Schweizer PA, Schröter J, Greiner S, Haas J, Yampolsky P, Mereles D, Buss SJ, Seyler C, Bruehl C, Draguhn A, Koenen M, Meder B, Katus HA, Thomas D. The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel. J Am Coll Cardiol. 2014;64:757-767. doi: 10.1016/j. jacc.2014.06.1155.
16. Hansen BJ, Zhao J, Csepe TA, Moore BT, Li N, Jayne LA, Kalyanasundaram A, Lim P, Bratasz A, Powell KA, Simonetti OP, Higgins RS, Kilic A, Mohler PJ, Janssen PM, Weiss R, Hummel JD, Fedorov VV. Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts. Eur Heart J. 2015;36:2390-3401. doi: 10.1093/eurheartj/ehv233.
17. Sánchez-Quintana D, Cabrera JA, Farré J, Climent V, Anderson RH, Ho SY. Sinus node revisited in the era of electroanatomical mapping and catheter ablation. Heart. 2005;91:189-194. doi: 10.1136/hrt.2003.031542.
18. Fedorov VV, Glukhov AV, Chang R. Conduction barriers and pathways of the sinoatrial pacemaker complex: their role in normal rhythm and atrial arrhythmias. Am J Physiol Heart Circ Physiol. 2012;302:H1773-H1783. doi: 10.1152/ajpheart.00892.2011.
19. Csepe TA, Kalyanasundaram A, Hansen BJ, Zhao J, Fedorov VV. Fibrosis: a structural modulator of sinoatrial node physiology and dysfunction. Front Physiol. 2015;6:37. doi: 10.3389/fphys.2015.00037.
20. Nixon BR, Thawornkaiwong A, Jin J, Brundage EA, Little SC, Davis JP, Solaro RJ, Biesiadecki BJ. AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function. J Biol Chem. 2012;287:19136-19147. doi: 10.1074/jbc.M111.323048.
21. Liu J, Dobrzynski H, Yanni J, Boyett MR, Lei M. Organisation of the mouse sinoatrial node: structure and expression of HCN channels. Cardiovasc Res. 2007;73:729-738. doi: 10.1016/j.cardiores.2006.11.016.
22. Bucchi A, Barbuti A, Difrancesco D, Baruscotti M. Funny current and cardiac rhythm: insights from HCN knockout and transgenic mouse models. Front Physiol. 2012;3:240. doi: 10.3389/fphys.2012.00240.
23. Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. J Am Coll Cardiol. 2012;60:1323-1329. doi: 10.1016/j.jacc.2012.06.031.
24. Borer JS, Fox K, Jaillon P, Lerebours G; Ivabradine Investigators Group. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation. 2003;107:817-823.
25. Lakatta EG, Maltsev VA, Vinogradova TM. A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circ Res. 2010;106:659-673. doi: 10.1161/CIRCRESAHA.109.206078.
26. Herrmann S, Layh B, Ludwig A. Novel insights into the distribution of cardiac HCN channels: an expression study in the mouse heart. J Mol Cell Cardiol. 2011;51:997-1006. doi: 10.1016/j.yjmcc.2011.09.005.
27. Brioschi C, Micheloni S, Tellez JO, Pisoni G, Longhi R, Moroni P, Billeter R, Barbuti A, Dobrzynski H, Boyett MR, DiFrancesco D, Baruscotti M. Distribution of the pacemaker HCN4 channel mRNA and protein in the rabbit sinoatrial node. J Mol Cell Cardiol. 2009;47:221-227. doi: 10.1016/j.yjmcc.2009.04.009.
28. Chandler N, Aslanidi O, Buckley D, Inada S, Birchall S, Atkinson A, Kirk D, Monfredi O, Molenaar P, Anderson R, Sharma V, Sigg D, Zhang H, Boyett M, Dobrzynski H. Computer three-dimensional anatomical reconstruction of the human sinus node and a novel paranodal area. Anat Rec (Hoboken). 2011;294:970-979. doi: 10.1002/ar.21379.
29. Ludwig A, Budde T, Stieber J, Moosmang S, Wahl C, Holthoff K, Langebartels A, Wotjak C, Munsch T, Zong X, Feil S, Feil R, Lancel M, Chien KR, Konnerth A, Pape HC, Biel M, Hofmann F. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J. 2003;22:216-224. doi: 10.1093/emboj/cdg032.
30. Atkinson AJ, Logantha SJ, Hao G, Yanni J, Fedorenko O, Sinha A, Gilbert SH, Benson AP, Buckley DL, Anderson RH, Boyett MR, Dobrzynski H. Functional, anatomical, and molecular investigation of the cardiac conduction system and arrhythmogenic atrioventricular ring tissue in the rat heart. J Am Heart Assoc. 2013;2:e000246. doi: 10.1161/JAHA.113.000246.
31. Li N, Hansen BJ, Csepe TA, Jayne L, Zhao J, Moore B, Higgins RS, Weiss R, Kilic A, Rosen MR, Mohler PJ, Biesiadecki BJ, Janssen PM, Fedorov VV. Functional and molecular characteristics of the latent atrial pacemaker clusters in explanted human hearts. Circulation. 2014;130:A18888.
32. DiFrancesco D. Serious workings of the funny current. Prog Biophys Mol Biol. 2006;90:13-25. doi: 10.1016/j.pbiomolbio.2005.05.001.
33. Bucchi A, Tognati A, Milanesi R, Baruscotti M, DiFrancesco D. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels. J Physiol. 2006;572(pt 2):335-346. doi: 10.1113/jphysiol.2005.100776.
34. Plotnikov AN, Bucchi A, Shlapakova I, Danilo P, Jr, Brink PR, Robinson RB, Cohen IS, Rosen MR. HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockade. Heart Rhythm. 2008;5:282-288. doi: 10.1016/j.hrthm.2007.09.028.
35. Moosmang S, Stieber J, Zong X, Biel M, Hofmann F, Ludwig A. Cellular expression and functional characterization of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues. Eur J Biochem. 2001;268:1646-1652.
36. Cerbai E, Mugelli A. I(f) in non-pacemaker cells: role and pharmacological implications. Pharmacol Res. 2006;53:416-423. doi: 10.1016/j. phrs.2006.03.015.
37. Fenske S, Mader R, Scharr A, Paparizos C, Cao-Ehlker X, Michalakis S, Shaltiel L, Weidinger M, Stieber J, Feil S, Feil R, Hofmann F, Wahl-Schott C, Biel M. HCN3 contributes to the ventricular action potential waveform in the murine heart. Circ Res. 2011;109:1015-1023. doi: 10.1161/CIRCRESAHA.111.246173.
38. Schweizer PA, Yampolsky P, Malik R, Thomas D, Zehelein J, Katus HA, Koenen M. Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. Basic Res Cardiol. 2009;104:621-629. doi: 10.1007/s00395-009-0031-5.
39. Stillitano F, Lonardo G, Giunti G, Del Lungo M, Coppini R, Spinelli V, Sartiani L, Poggesi C, Mugelli A, Cerbai E. Chronic atrial fibrillation alters the functional properties of If in the human atrium. J Cardiovasc Electrophysiol. 2013;24:1391-1400. doi: 10.1111/jce.12212.
40. Stillitano F, Lonardo G, Zicha S, Varro A, Cerbai E, Mugelli A, Nattel S. Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol. 2008;45:289-299. doi: 10.1016/j.yjmcc.2008.04.013.
41. Cai J, Yi FF, Li YH, Yang XC, Song J, Jiang XJ, Jiang H, Lin GS, Wang W. Adenoviral gene transfer of HCN4 creates a genetic pacemaker in pigs with complete atrioventricular block. Life Sci. 2007;80:1746-1753. doi: 10.1016/j.lfs.2007.02.006.
42. Plotnikov AN, Shlapakova I, Szabolcs MJ, Danilo P, Jr, Lorell BH, Potapova IA, Lu Z, Rosen AB, Mathias RT, Brink PR, Robinson RB, Cohen IS, Rosen MR. Xenografted adult human mesenchymal stem cells provide a platform for sustained biological pacemaker function in canine heart. Circulation. 2007;116:706-713. doi: 10.1161/CIRCULATIONAHA.107.703231.
43. Tse HF, Xue T, Lau CP, Siu CW, Wang K, Zhang QY, Tomaselli GF, Akar FG, Li RA. Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN Channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model. Circulation. 2006;114:1000-1011. doi: 10.1161/CIRCULATIONAHA.106.615385.